PBS approval for new once-a-day diabetes medications 9 December 2014 New once-a-day fixed-dose medications for people with type 2 diabetes have been approved for inclusion on the Pharmaceutical Benefits Scheme (PBS). The two new treatments are linagliptin with metformin (sold as Trajenta Duo), and saxagliptin with metformin (sold as Kombiglyze). Federal Health Minister Peter Dutton said that while people with type 2 diabetes already have access to the individual medications through the PBS, some need to use a combination of medicines to treat their diabetes. “With the combination dose now listed on the PBS, these patients will save up to $36.90 every time they get a script filled because they will only have to buy one fixed dose medicine instead of two,†Mr Dutton said. The new treatments are available via prescription. For more information, please contact your doctor or endocrinologist.
Media releases 18 July 2025 Youfoodz partners with Diabetes Australia to support Australians living with diabetes Youfoodz, a HelloFresh company, and one of Australia’s leading ready-made meal providers, has today confirmed a new national partnership with... Continue Reading
Media releases 18 July 2025 Bold new policy and KeepSight reports drive prevention and care Diabetes Australia has marked National Diabetes Week (13 – 19 July 2025) with two major initiatives designed to tackle Australia’s... Continue Reading
Media releases 17 July 2025 AI health app to supercharge living well with type 2 diabetes Australians living with or at risk of developing type 2 diabetes will, for the first time, have free access to... Continue Reading